IDT Australia Limited

ASX:IDT ISIN:AU000000IDT0

Supply of products and provision of research and development and other technical services for the pharmaceutical and allied industries. 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 12315

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article

Institute Of Drug Technology Australia Limited ASX: IDT - Expands Drug Development Relationship With Pfizer - Dr Graeme Blackman, Chairman & Managing Director

🕔1/29/2007 11:07:00 AM 3039

Institute Of Drug Technology Australia Limited (ASX: IDT) - Expands Drug Development Relationship With Pfizer - Dr Graeme Blackman, Chairman & Managing Director; Boardroomradio is pleased to announce that Institute Of Drug Technology Australia Limited (ASX: IDT) has published an audio file.

Read Full Article
###

3,287 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 24) (Since Published: 3287) 

Company Data

    Fax
  • (03) 9801 8773 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 1991/02/18 
  • Homepage
  • www.idtaus.com.au/

More News Results

  • 2024/07/10: Change in substantial holding from SNC*
  • 2024/07/10: Application for quotation of securities - IDT*
  • 2024/07/10: Completion of Entitlement Offer*
  • 2024/06/27: Reminder of IDT Entitlement Offer Closing Date*
  • 2024/06/13: IDT Despatches Entitlement Offer Booklet*
  • 2024/06/11: Update on Indicative Proposal from Mynd*
  • 2024/06/05: Ceasing to be a substantial holder*
  • 2024/06/04: Update - Proposed issue of securities - IDT*
  • 2024/06/04: Correction - Entitlement Offer To Raise $7m at 9c Per Share*
  • 2024/06/04: Cleansing Notice*
*refer to company website